Product Program year 2025 Source: CMS Open Payments

Symbravo

Drug Neurology

NDC 81968-020-02

Open in the dashboard

General payments

$3,109,544

20,403 payments

Research payments

$0

0 payments

Through program year 2025, $3,109,544 in general payments and $0 in research payments were reported against Symbravo (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $3,109,544 20,403

Breakdown

Who paid General payments · program year 2025
  1. Axsome Therapeutics, Inc. $3,109,544 20,403 payments
Top recipients General payments · program year 2025
  1. Eric Eross Neurology · Phoenix, AZ $106,812 3% · 101 payments
  2. Stewart Tepper Neurology · Stamford, CT $85,260 3% · 53 payments
  3. Christopher Rhyne Family Medicine · Louisville, KY $82,358 3% · 117 payments
  4. Andrew Blumenfeld Neurology · Carlsbad, CA $67,135 2% · 77 payments
  5. Audrey Halpern Neurology · New York, NY $47,842 2% · 65 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology Psychiatry & Neurology $1,973,467 65% · 1,852 practitioners
  2. Family Medicine $192,115 6% · 1,374 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $171,436 6% · 1,539 practitioners
  4. Internal Medicine $127,491 4% · 737 practitioners
  5. Physician Assistant $92,465 3% · 821 practitioners

The top 5 of 121 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $403,543 13% · 725 recipients
  2. California $325,664 10% · 592 recipients
  3. Illinois $223,167 7% · 311 recipients
  4. Florida $195,641 6% · 587 recipients
  5. Texas $182,184 6% · 891 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

20,403 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record